Sandoz Sued Over Schizophrenia Drug Patent
A Japanese pharmaceutical company has filed a patent infringement suit against the generics arm of Novartis AG in response to the subsidiary's bid to obtain U.S. regulatory approval for a generic...To view the full article, register now.
Already a subscriber? Click here to view full article